Psoriasis: all 1,928 studies
Page 15 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque PsoriasisWithdrawnNCT02970331Phase 2
- Comparation of Ultrasonic Imaging of Enthesopathy in Patients With Psoriatic Arthritis and PsoriasisStatus unknownNCT02962271
- Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008CompletedNCT02955693Phase 1
- Microneedle Patch for Psoriatic PlaquesStatus unknownNCT02955576Not applicable
- APremilast After FumaRic Acid Ester TreatmentCompletedNCT02954081
- Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02949388Phase 2
- Psychotherapy for Patients With Psoriasis: Effects in Quality of LifeStatus unknownNCT02944630Not applicable
- BE Study in Patients - Methotrexate TabletsStatus unknownNCT02940561Phase 1
- BAY1003803 Formulation Comparison in Open Psoriasis Plaque TestCompletedNCT02940002Phase 1
- BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics StudyTerminatedNCT02936492Phase 1
- PSOREAL - Managing PSOriasis in the REAL WorldCompletedNCT02935582
- A Study of SHR-1314 in Healthy SubjectsCompletedNCT02934412Phase 1
- Single Cell Genomics of Psoriatic SkinCompletedNCT02929745Not applicable
- Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisCompletedNCT02922192
- Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type PsoriasisStatus unknownNCT02918123Phase 1
- Effects of Weight-loss Treatment in Obese Patients With Psoriatic ArthritisCompletedNCT02917434Not applicable
- The Role of Bacterial Toxins in Human Skin DiseaseStatus unknownNCT02910791
- Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)CompletedNCT02902861Phase 3
- Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of PsoriasisCompletedNCT02899429
- A Study of LY3041658 in Participants With Skin DiseasesCompletedNCT02896868Phase 1
- LEO 32731 for the Treatment of Moderate to Severe Psoriasis VulgarisCompletedNCT02888236Phase 2
- Efficacy and Tolerability of Enstilar® in Daily PracticeCompletedNCT02881346
- Real-life Evaluation of the Daivobet® Gel ApplicatorCompletedNCT02856542
- Oral Psoriasis Treatment Adherence and Intervention StudyCompletedNCT02850900Not applicable
- Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic ArthritisCompletedNCT02849795Not applicable
- Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe PsoriasisTerminatedNCT02829424Phase 4
- Distal Erosions and Nail PsoriasisStatus unknownNCT02813720
- PASIMAT: Automatic Measure of PASICompletedNCT02808559Not applicable
- Icotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisCompletedNCT02801435Phase 1
- TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current TreatmentCompletedNCT02796053Phase 1/2
- Assessment of Dermatologic Family Impact Scale in the Parents of Children With PsoriasisCompletedNCT02796014
- Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish PopulationWithdrawnNCT02795416Phase 3
- Study to Evaluate Broadlumab vs Placebo and UstekinumabTerminatedNCT02786732Phase 3
- A Registry of Patients With Moderate to Severe Plaque PsoriasisCompletedNCT02786186
- Apremilast Pregnancy Exposure RegistryActive, not recruitingNCT02775500
- This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic ArthritisCompletedNCT02772601Phase 1
- Safety Study of BMS-986202 in Healthy Subjects and to Treat PsoriasisCompletedNCT02763969Phase 1
- Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT02762955Phase 3
- A Phase I Study With LEO 32731 and Midazolam in Healthy Male SubjectsTerminatedNCT02753218Phase 1
- Study on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque PsoriasisCompletedNCT02752672
- Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp PsoriasisStatus unknownNCT02749656Phase 3
- A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology PracticeCompletedNCT02740218
- A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.CompletedNCT02733874Phase 4
- Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin CapsulesStatus unknownNCT02715960Phase 2
- Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by MethotrexateStatus unknownNCT02715947Phase 2
- MYL-1401A Efficacy and Safety Comparability Study to Humira®CompletedNCT02714322Phase 3
- A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in GreeceCompletedNCT02713295
- Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque PsoriasisStatus unknownNCT02701205Phase 3
- Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse PsoriasisCompletedNCT02695940Phase 2
- The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)Status unknownNCT02693470Phase 4
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035CompletedNCT02690142Phase 1
- Cross Sectional Analysis of Healthcare for Psoriasis in 4 European CountriesStatus unknownNCT02668341
- Comparison Study of Psoriasis Severity Assessment ToolsCompletedNCT02655705Phase 4
- Observational Study of Apremilast in Patients With Psoriasis in The NetherlandsCompletedNCT02652494
- Cutaneous Microcirculation and Nervous Sensitivity in PsoriasisCompletedNCT02652065Not applicable
- Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese PsoriasisTerminatedNCT02649270Phase 1
- Assessing the Efficacy and Safety of Metformin in Treatment of Moderate PsoriasisStatus unknownNCT02644954Phase 3
- Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional StudyCompletedNCT02636101
- Multiple Ascending Dose Study of PRX003 in Subjects With PsoriasisCompletedNCT02630901Phase 1
- A Study of Otezla® in Patients With Plaque Psoriasis Under Routine ConditionsCompletedNCT02626793
- Proton Pump Inhibitors Use in Patients With PsoriasisWithdrawnNCT02624544Phase 4
- Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque PsoriasisCompletedNCT02607774Phase 1
- Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by PsoriasisCompletedNCT02606760Phase 3
- Dermatopharmacokinetic Trial of LEO 80185 GelCompletedNCT02605057Phase 1
- Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease ActivityCompletedNCT02602925Phase 4
- Anti-psoriatic Effect of TL01 Light TherapyCompletedNCT02599415Not applicable
- Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis PatientsCompletedNCT02576197Not applicable
- Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis PatientsCompletedNCT02574091Phase 1
- An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic PatientsCompletedNCT02555709Phase 1/2
- Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque PsoriasisCompletedNCT02548052Phase 1
- Safety Study of BMS-986165 in Healthy Subjects and to Treat PsoriasisCompletedNCT02534636Phase 1
- Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese PopulationCompletedNCT02533973Phase 4
- A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With PsoriasisCompletedNCT02529956Phase 1
- LEO 32731 - A Phase I Study in Healthy SubjectsCompletedNCT02514694Phase 1
- Etanercept Survival in Elderly PopulationCompletedNCT02503059
- Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type PsoriasisTerminatedNCT02502188Phase 1
- Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque PsoriasisCompletedNCT02494479Phase 2
- Safety and Efficacy of UC-MSCs in Patients With Psoriasis VulgarisStatus unknownNCT02491658Phase 1/2
- Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque PsoriasisCompletedNCT02489643Not applicable
- Psoriasis-Arthritis & Bone ProgramCompletedNCT02483234Phase 2
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy StudyWithdrawnNCT02472717Phase 2
- Single Ascending Dose Study of PRX003 in Healthy SubjectsCompletedNCT02458677Phase 1
- Sleep, Circadian Rhythm & Skin HealthCompletedNCT02457000
- Luma Light System Proof of Concept Study in Subjects With Mild to Moderate PsoriasisStatus unknownNCT02447068Not applicable
- A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque PsoriasisCompletedNCT02435342Phase 1
- Trial to Evaluate Topical C-82 in a Psoriasis Plaque TestCompletedNCT02432027Phase 1/2
- The Association Between Psoriasis and Intestinal Bacterial PopulationCompletedNCT02417792
- A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)CompletedNCT02416258Phase 2
- Serum, Cellular and Imaging Markers of Arthritis in Psoriasis PatientsCompletedNCT02413801
- Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapyTerminatedNCT02408159Phase 4
- Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With PsoriasisCompletedNCT02397382Phase 1
- Efficacy of Novel Drug-combinations for Relief of PsoriasisSuspendedNCT02394301
- A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With PsoriasisCompletedNCT02382081Not applicable
- On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus InfectionCompletedNCT02376478
- Diabetes and PsoriasisCompletedNCT02366273
- Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)CompletedNCT02347501Phase 2
- An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCompletedNCT02343744Phase 3
- A Clinical Study of Subclinical Enthesitis and Synovitis in Patients With Vulgaris PsoriasisStatus unknownNCT02339636
- Comparative Effectiveness of Psoriasis Treatments on Systemic InflammationCompletedNCT02330380
- Natural Gels for Treatment of Plaque PsoriasisCompletedNCT02330237Phase 2/3